Sulopenem etzadroxil and probenecid – Oral Products

	Minimum Inhibitory Concentrations (mcg/mL)			Disk Diffusion (zone diameter in mm)
Pathogen	S	I	R	S	I	R
Enterobacteralesa	≤ 0.25	0.5	≥ 1.0	≥ 19	16-18	≤ 15

S = susceptible; I = intermediate; R = resistant

^a Clinical efficacy was shown for E. coli, K. pneumoniae, and P. mirabilis.